申请人:Eli Lilly and Company
公开号:US03989831A1
公开(公告)日:1976-11-02
3-Chloro-5,6-diaryl-1,2,4-triazines, topically active anti-inflammatory agents, having the formula ##SPC1## Wherein R.sub.2 and R.sub.3 independently are halo, C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy, or di(C.sub.1 -C.sub.3 alkyl)amino; and the pharmaceutically-acceptable acid addition salts of basic members thereof.
3-氯-5,6-二芳基-1,2,4-三嗪是一种具有局部活性的抗炎药物,其化学式为##SPC1## 其中R.sub.2和R.sub.3独立地是卤素、C.sub.1-C.sub.3烷基、C.sub.1-C.sub.3烷氧基或双(C.sub.1-C.sub.3烷基)氨基;以及其碱性成员的药学上可接受的酸盐。